StockData
Azitra, Inc. logo

Azitra, Inc. (AZTR) stock

AZTRNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.61−0.02 (-3.03%)

Close on Nov 17, 2026Market cap $36.85MP/E –Yield –

Azitra price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Azitra's price to sales ratio was 329.0× on Apr 30, 2025, against 3.9× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 2025329.0×+295.7
2024Dec 31, 202433.3×+15.5
2023Dec 29, 202317.8×–

More Azitra figures

See a number that looks wrong?